| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 10.235 | 10.748 | 10.320 | 10.514 | 7.189 | 7.269 | 3.199 | 3.791 |
| Total Income - EUR | - | - | 10.235 | 10.748 | 10.320 | 10.530 | 8.798 | 7.573 | 3.648 | 3.841 |
| Total Expenses - EUR | - | - | 5.444 | 6.497 | 9.200 | 7.759 | 5.062 | 10.288 | 8.096 | 5.443 |
| Gross Profit/Loss - EUR | - | - | 4.791 | 4.251 | 1.120 | 2.772 | 3.735 | -2.715 | -4.448 | -1.602 |
| Net Profit/Loss - EUR | - | - | 4.491 | 3.929 | 811 | 2.497 | 3.519 | -2.901 | -4.448 | -1.602 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Vitruvia Medica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 2.915 | 3.314 | 4.166 | 2.975 | 4.785 | 2.986 |
| Current Assets | - | - | 5.249 | 9.261 | 8.122 | 8.420 | 6.123 | 3.208 | 1.342 | 1.642 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 158 | 1.545 | 845 | 1.597 | 1.664 | 2.224 | 1.205 | 1.244 |
| Cash | - | - | 5.092 | 7.716 | 7.277 | 6.823 | 4.458 | 984 | 137 | 398 |
| Shareholders Funds | - | - | 4.535 | 8.381 | 9.030 | 11.356 | 9.570 | 5.883 | 1.417 | -194 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 714 | 880 | 2.007 | 378 | 100 | 23 | 4.749 | 4.885 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 657 | 355 | 51 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Vitruvia Medica S.r.l.